SCHEMBL9934807

SCHEMBL9934807

CCOC=CC(=O)OCCN

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.44
HCAR2 Q8TDS4 5/20 0.41
MAPT P10636 3/20 0.38
RAB9A P51151 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CASP1 P29466 1/20 0.36
CYP1A2 P05177 1/20 0.34
CTH P32929 1/20 0.34
ALDH1A1 P00352 1/20 0.34
THRB P10828 1/20 0.34
CNR1 P21554 1/20 0.34
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
LMNA P02545 1/20 0.33
ALOX15 P16050 1/20 0.32
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA7 P43166 1/20 0.32
CA9 Q16790 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11444835 0.85 HCAR2 (0.48) ATMHCAR2MAPTRAB9ANPSR1
SCHEMBL361271 0.84 HCAR2 (0.59) ATMHCAR2MAPTRAB9ANPSR1
SCHEMBL1888855 0.84 HCAR2 (0.59) ATMHCAR2MAPTRAB9ANPSR1
Hydrochloric Acid SCHEMBL8307529 0.83 HCAR2 (0.47) ATMHCAR2MAPTNPSR1CYP1A2
SCHEMBL10414957 0.82 HCAR2 (0.59) ATMHCAR2MAPTRAB9ANPSR1
SCHEMBL94677 0.81 HCAR2 (0.58) ATMHCAR2MAPTNPSR1CASP1
SCHEMBL94676 0.81 HCAR2 (0.58) ATMHCAR2MAPTNPSR1CASP1
SCHEMBL6445496 0.81 HCAR2 (0.58) ATMHCAR2MAPTNPSR1CASP1
SCHEMBL196924 0.81 ATM (0.70) ATMHCAR2MAPTRAB9ANPSR1
SCHEMBL1877470 0.81 ATM (0.70) ATMHCAR2MAPTRAB9ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9249179-B2 Galactose cluster-pharmacokinetic modulator targeting moiety for siRNA Arrowhead Madison Inc. (US) 2016-02-02 US disclosed
US-20120157509-A1 GALACTOSE CLUSTER-PHARMACOKINETIC MODULATOR TARGETING MOIETY FOR siRNA ARROWHEAD RESEARCH CORPORATION 2012-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120157509-A1 GALACTOSE CLUSTER-PHARMACOKINETIC MODULATOR TARGETING MOIETY FOR siRNA GALK1, GALE, GALNT6 ATM 4798/4885HCAR2 908/4885MAPT 1855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.